Budiodarone

DB05519InvestigationalSmall molecule

Budiodarone (ATI-2042) is an antiarrhythmic related to amiodarone that is currently being studied in clinical trials.

Chemical structure of Budiodarone
Primary indication
Investigated for use/treatment in arrhythmia and atrial fibrillation.Curator reviewed
Formula / weight
C27H31I2NO5 · 703.356 g/mol (avg)
Code names
ATI-2042

Resolves to

Compound
UNIIF5Y53150C8CAS335148-45-3ChEMBLCHEMBL2105631
Structure
InChIKeyZXOSVKYCXLTVGS-KRWDZBQOSA-NSMILESCC[C@H](C)OC(=O)CC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2

What you can answer from here — as of September 23, 2026

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Budiodarone, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In